Prognostic impact of discordance in hormone receptor status after the neoadjuvant chemotherapy in primary breast cancer

被引：0
|
作者：
Kurihara, Toshiaki [1 ]
Ueno, Hanako [1 ]
Takemae, Masaru [1 ]
Nagayama, Aiko [1 ]
Takahashi, Maiko [1 ]
Hayashida, Tetsu [1 ]
Jinno, Hiromitsu [1 ]
Kitagawa, Yuko [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo 108, Japan
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P3-06-49
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-06-49
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The discordance of the ER, PR, and HER2 status after neoadjuvant chemotherapy in breast cancer.
    Ustaalioglu, Basak Oven
    Bilici, Ahmet
    Aker, Fugen Vardar
    Erkol, Burcak
    Aliustaoglu, Mehmet
    Gurleyik, Gunay
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis
    Dieci, M. V.
    Barbieri, E.
    Piacentini, F.
    Ficarra, G.
    Bettelli, S.
    Dominici, M.
    Conte, P. F.
    Guarneri, V.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 101 - 108
  • [23] Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer
    Hirata, T.
    Shimizu, C.
    Yonemori, K.
    Hirakawa, A.
    Kouno, T.
    Tamura, K.
    Ando, M.
    Katsumata, N.
    Fujiwara, Y.
    BRITISH JOURNAL OF CANCER, 2009, 101 (09) : 1529 - 1536
  • [24] Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer
    T Hirata
    C Shimizu
    K Yonemori
    A Hirakawa
    T Kouno
    K Tamura
    M Ando
    N Katsumata
    Y Fujiwara
    British Journal of Cancer, 2009, 101 : 1529 - 1536
  • [25] Clinical factors associated with discordance in hormone receptor status between primary and recurrent breast cancer
    Shiino, S.
    Kinoshita, T.
    Yoshida, M.
    Jimbo, K.
    Asaga, S.
    Takayama, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S42 - S42
  • [26] Impact of hormone receptor and HER2 conversions on survival after neoadjuvant chemotherapy in breast cancer patients
    Ran Feng
    Lihui Pan
    Yarong Yao
    Jinnan Gao
    Xiaojun Zhang
    Oncology and Translational Medicine, 2025, 11 (02) : 73 - 80
  • [27] CAN THE HORMONAL RECEPTOR STATUS OF PRIMARY BREAST-CANCER BE ALTERED BY NEOADJUVANT CHEMOTHERAPY
    LO, SS
    WANG, HC
    SHYR, YM
    LUI, WY
    JOURNAL OF SURGICAL ONCOLOGY, 1994, 57 (02) : 94 - 96
  • [28] Receptor Status Change From Primary to Residual Breast Cancer After Neoadjuvant Chemotherapy and Analysis of Survival Outcomes
    Parinyanitikul, Napa
    Lei, Xiudong
    Chavez-MacGregor, Mariana
    Liu, Shuying
    Mittendorf, Elizabeth A.
    Litton, Jennifer K.
    Woodward, Wendy
    Zhang, Amy
    Hortobagyi, Gabriel N.
    Valero, Vicente
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    CLINICAL BREAST CANCER, 2015, 15 (02) : 153 - 160
  • [29] The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype
    Hayashi, Naoki
    Takahashi, Yuko
    Matsuda, Naoko
    Tsunoda, Hiroko
    Yoshida, Atsushi
    Suzuki, Koyu
    Nakamura, Seigo
    Yamauchi, Hideko
    CLINICAL BREAST CANCER, 2018, 18 (02) : E219 - E229
  • [30] Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy
    Yang, Libo
    Zhong, Xiaorong
    Pu, Tianjie
    Qiu, Yan
    Ye, Feng
    Bu, Hong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
12345